Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan-Ruide Li

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Nature Communications|February 1, 2025
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignanciesYan-Ruide Li, Ying Fang, Siyue Niu, et al.
Cell|May 22, 2025
Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axisBo Li, James Elsten-Brown, Miao Li, et al.
Nature Biomedical Engineering|April 15, 2025
Author Correction: Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Cell Reports. Medicine|August 30, 2025
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cellsYan-Ruide Li, Junhui Hu, Zhe Li, et al.
Nature Biomedical Engineering|October 25, 2024
Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Nature Cardiovascular Research|February 16, 2026
Self-powered in-stent restenosis diagnosis via magnetoelastic stentsGuorui Chen, Wi Jin Kim, Youcheng Yang, et al.
Science Immunology|May 15, 2021
Targeting monoamine oxidase A for T cell-based cancer immunotherapyXi Wang, Bo Li, Yu Jeong Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2024
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Cell Reports|December 17, 2021
HLA-A<sup>∗</sup>02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronavirusesPavlo A Nesterenko, Jami McLaughlin, Brandon L Tsai, et al.
Cell Reports. Medicine|November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Nature Communications|February 1, 2025
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignanciesYan-Ruide Li, Ying Fang, Siyue Niu, et al.
Cell|May 22, 2025
Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axisBo Li, James Elsten-Brown, Miao Li, et al.
Nature Biomedical Engineering|April 15, 2025
Author Correction: Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Cell Reports. Medicine|August 30, 2025
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cellsYan-Ruide Li, Junhui Hu, Zhe Li, et al.
Nature Biomedical Engineering|October 25, 2024
Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Nature Cardiovascular Research|February 16, 2026
Self-powered in-stent restenosis diagnosis via magnetoelastic stentsGuorui Chen, Wi Jin Kim, Youcheng Yang, et al.
Science Immunology|May 15, 2021
Targeting monoamine oxidase A for T cell-based cancer immunotherapyXi Wang, Bo Li, Yu Jeong Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2024
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Cell Reports|December 17, 2021
HLA-A<sup>∗</sup>02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronavirusesPavlo A Nesterenko, Jami McLaughlin, Brandon L Tsai, et al.
Cell Reports. Medicine|November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Pageof 10